The DOI matches its Crossref record; 136 of the 136 references it cites were found in a registry or an index.
Colorectal Cancer Screening: Recommendations for Physicians and Patients from the U.S. Multi-Society Task Force on Colorectal Cancer
Abstract
This document updates the colorectal cancer (CRC) screening recommendations of the U.S. Multi-Society Task Force of Colorectal Cancer (MSTF), which represents the American College of Gastroenterology, the American Gastroenterological Association, and The American Society for Gastrointestinal Endoscopy. CRC screening tests are ranked in 3 tiers based on performance features, costs, and practical considerations. The first-tier tests are colonoscopy every 10 years and annual fecal immunochemical test (FIT). Colonoscopy and FIT are recommended as the cornerstones of screening regardless of how screening is offered. Thus, in a sequential approach based on colonoscopy offered first, FIT should be offered to patients who decline colonoscopy. Colonoscopy and FIT are recommended as tests of choice when multiple options are presented as alternatives. A risk-stratified approach is also appropriate, with FIT screening in populations with an estimated low prevalence of advanced neoplasia and colonoscopy screening in high prevalence populations. The second-tier tests include CT colonography every 5 years, the FIT-fecal DNA test every 3 years, and flexible sigmoidoscopy every 5 to 10 years. These tests are appropriate screening tests, but each has disadvantages relative to the tier 1 tests. Because of limited evidence and current obstacles to use, capsule colonoscopy every 5 years is a third-tier test. We suggest that the Septin9 serum assay (Epigenomics, Seattle, Wash) not be used for screening. Screening should begin at age 50 years in average-risk persons, except in African Americans in whom limited evidence supports screening at 45 years. CRC incidence is rising in persons under age 50, and thorough diagnostic evaluation of young persons with suspected colorectal bleeding is recommended. Discontinuation of screening should be considered when persons up to date with screening, who have prior negative screening (particularly colonoscopy), reach age 75 or have <10 years of life expectancy. Persons without prior screening should be considered for screening up to age 85, depending on age and comorbidities. Persons with a family history of CRC or a documented advanced adenoma in a first-degree relative age <60 years or 2 first-degree relatives with these findings at any age are recommended to undergo screening by colonoscopy every 5 years, beginning 10 years before the age at diagnosis of the youngest affected relative or age 40, whichever is earlier. Persons with a single first-degree relative diagnosed at ≥60 years with CRC or an advanced adenoma can be offered average-risk screening options beginning at age 40 years.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevention of Colorectal Cancer by Colonoscopic Polypectomy
Winawer, S. J., Zauber, A. G., Ho, M. N., O'Brien, M. J., Gottlieb, L. S., Sternberg, S. S., Waye, J. D., Schapiro, M., Bond, J. H., Panish, J. F., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312303292701 · Cited by 4,592
Colonoscopic Polypectomy and Long-Term Prevention of Colorectal-Cancer Deaths
Zauber, A. G., Winawer, S. J., O'Brien, M. J., Lansdorp-Vogelaar, I., van Ballegooijen, M., Hankey, B. F., Shi, W., Bond, J. H., Schapiro, M., Panish, J. F., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1100370 · Cited by 3,185
Levin, B., Lieberman, D. A., McFarland, B., Andrews, K. S., Brooks, D., Bond, J., Dash, C., Giardiello, F. M., Glick, S., Johnson, D., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.02.002 · Cited by 2,990
Self-citationColorectal cancer statistics, 2014
Siegel, R., DeSantis, C., & Jemal, A. (2014) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21220 · Cited by 2,562
Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement
US Preventive Services Task Force, Bibbins-Domingo, K., Grossman, D. C., Curry, S. J., Davidson, K. W., Epling, J. W., García, F. A. R., Gillman, M. W., Harper, D. M., Kemper, A. R., et al. (2016) · JAMA · doi:10.1001/jama.2016.5989 · Cited by 2,509
Adenoma detection rate and risk of colorectal cancer and death
Corley, D. A., Jensen, C. D., Marks, A. R., Zhao, W. K., Lee, J. K., Doubeni, C. A., Zauber, A. G., de Boer, J., Fireman, B. H., Schottinger, J. E., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1309086 · Cited by 2,270
Self-citationQuality Indicators for Colonoscopy and the Risk of Interval Cancer
Kaminski, M. F., Regula, J., Kraszewska, E., Polkowski, M., Wojciechowska, U., Didkowska, J., Zwierko, M., Rupinski, M., Nowacki, M. P., & Butruk, E. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907667 · Cited by 2,010
Multitarget Stool DNA Testing for Colorectal-Cancer Screening
Imperiale, T. F., Ransohoff, D. F., Itzkowitz, S. H., Levin, T. R., Lavin, P., Lidgard, G. P., Ahlquist, D. A., & Berger, B. M. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1311194 · Cited by 1,900
Self-citationLieberman, D. A., Rex, D. K., Winawer, S. J., Giardiello, F. M., Johnson, D. A., & Levin, T. R. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.06.001 · Cited by 1,892
Self-citationQuality indicators for colonoscopy
Rex, D. K., Schoenfeld, P. S., Cohen, J., Pike, I. M., Adler, D. G., Fennerty, M. B., Lieb, J. G., Park, W. G., Rizk, M. K., Sawhney, M. S., et al. (2015) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2014.07.058 · Cited by 1,764
Self-citation
Cited by
Wang, P., Berzin, T. M., Glissen Brown, J. R., Bharadwaj, S., Becq, A., Xiao, X., Liu, P., Li, L., Song, Y., Zhang, D., et al. (2019) · Gut · doi:10.1136/gutjnl-2018-317500 · Cited by 865
ACG Clinical Guidelines: Colorectal Cancer Screening 2021
Shaukat, A., Kahi, C. J., Burke, C. A., Rabeneck, L., Sauer, B. G., & Rex, D. K. (2021) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001122 · Cited by 853
Self-citationA comprehensive review and update on ulcerative colitis,
Gajendran, M., Loganathan, P., Jimenez, G., Catinella, A. P., Ng, N., Umapathy, C., Ziade, N., & Hashash, J. G. (2019) · Disease-a-Month · doi:10.1016/j.disamonth.2019.02.004 · Cited by 638
Current and future colorectal cancer screening strategies
Shaukat, A., & Levin, T. R. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00612-y · Cited by 516
Self-citationEarly-onset colorectal cancer: initial clues and current views
Hofseth, L. J., Hebert, J. R., Chanda, A., Chen, H., Love, B. L., Pena, M. M., Murphy, E. A., Sajish, M., Sheth, A., Buckhaults, P. J., et al. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0253-4 · Cited by 428
Wang, P., Liu, X., Berzin, T. M., Glissen Brown, J. R., Liu, P., Zhou, C., Lei, L., Li, L., Guo, Z., Lei, S., et al. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(19)30411-x · Cited by 415
Screening and prevention of colorectal cancer
Kanth, P., & Inadomi, J. M. (2021) · BMJ · doi:10.1136/bmj.n1855 · Cited by 358
Davis, B. R., Lee-Kong, S. A., Migaly, J., Feingold, D. L., & Steele, S. R. (2018) · Diseases of the Colon & Rectum · doi:10.1097/dcr.0000000000001030 · Cited by 344
Bénard, F., Barkun, A. N., Martel, M., & Renteln, D. V. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i1.124 · Cited by 306
Risk Factors Associated With Early-Onset Colorectal Cancer
Gausman, V., Dornblaser, D., Anand, S., Hayes, R. B., O'Connell, K., Du, M., & Liang, P. S. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.10.009 · Cited by 298
Gallo, G., Martellucci, J., Sturiale, A., Clerico, G., Milito, G., Marino, F., Cocorullo, G., Giordano, P., Mistrangelo, M., & Trompetto, M. (2020) · Techniques in Coloproctology · doi:10.1007/s10151-020-02149-1 · Cited by 290
Spaander, M. C. W., Zauber, A. G., Syngal, S., Blaser, M. J., Sung, J. J., You, Y. N., & Kuipers, E. J. (2023) · Nature Reviews Disease Primers · doi:10.1038/s41572-023-00432-7 · Cited by 288
Colon Cancer: A Clinician’s Perspective in 2019
Ahmed, M. (2020) · Gastroenterology Research · doi:10.14740/gr1239 · Cited by 275
Screening for Colorectal Cancer
Gupta, S. (2022) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2022.02.001 · Cited by 212
Study on detection rate of polyps and adenomas in artificial-intelligence-aided colonoscopy
Huang, J., Liu, W.-N., Zhang, Y.-Y., Bian, X.-Q., Wang, L.-J., Yang, Q., & Zhang, X.-D. (2020) · Saudi Journal of Gastroenterology · doi:10.4103/sjg.sjg_377_19 · Cited by 179
Colonoscopy screening and surveillance guidelines
Saito, Y., Oka, S., Kawamura, T., Shimoda, R., Sekiguchi, M., Tamai, N., Hotta, K., Matsuda, T., Misawa, M., Tanaka, S., et al. (2021) · Digestive Endoscopy · doi:10.1111/den.13972 · Cited by 170
Cardoso, R., Guo, F., Heisser, T., Hoffmeister, M., & Brenner, H. (2020) · Cancers · doi:10.3390/cancers12061409 · Cited by 102
Carneiro, G., Zorron Cheng Tao Pu, L., Singh, R., & Burt, A. (2020) · Medical Image Analysis · doi:10.1016/j.media.2020.101653 · Cited by 76
A novel AI device for real-time optical characterization of colorectal polyps
Biffi, C., Salvagnini, P., Dinh, N. N., Hassan, C., Sharma, P., GI Genius CADx Study Group, Antonelli, G., Awadie, H., Bernhofer, S., Carballal, S., et al. (2022) · npj Digital Medicine · doi:10.1038/s41746-022-00633-6 · Cited by 54
“…visual differentiation between adenomatous and non-adenomatous polyps (optical characterization, OC) during colonoscopy is clinically relevant to select optimal treatment regimen, avoid inappropriate endoscopic resection, improve cost-effectiveness, and reduce the number of polypectomies 3,4 .”
BackgroundCancer mortality in the oldest old: a global overview
Hashim, D., Carioli, G., Malvezzi, M., Bertuccio, P., Waxman, S., Negri, E., La Vecchia, C., & Boffetta, P. (2020) · Aging · doi:10.18632/aging.103503 · Cited by 36
A “Sludge Audit” for Health System Colorectal Cancer Screening Services
(2023) · The American Journal of Managed Care · doi:10.37765/ajmc.2023.89402 · Cited by 10
Metadata
- Authors
- Rex, D. K., Boland, R. C., Dominitz, J. A., Giardiello, F. M., Johnson, D. A., Kaltenbach, T., Levin, T. R., Lieberman, D., & Robertson, D. J.
- Venue
- American Journal of Gastroenterology
- Published
- 2017-07
- Volume
- 112
- Issue
- 7
- Pages
- 1016-1030
- ISSN
- 0002-9270 (ISSN-L)
- OpenAlex
- W2619143830
- Cited by
- 811
- References
- 136
- FWCI
- 32.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.